Literature DB >> 7542910

Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations.

O A Bernard1, R Berger.   

Abstract

Chromosomal abnormalities of the 11q23 band occur frequently in various hematopoietic malignant disorders. Because numerous partner chromosomes have been previously described, it is now important to determine the number of genes involved at 11q23 and to clarify the role of the partner genes. Recent efforts in several laboratories have identified a trithorax-related gene that is involved in most of the 11q23 abnormalities. The aim of this review is to summarize the recent data concerning these 11q23 rearrangements and the understanding of their consequences.

Entities:  

Mesh：

Year:  1995        PMID： 7542910     DOI： 10.1002/gcc.2870130202

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN： 1045-2257            Impact factor:   5.006


  27 in total

1.  CD3+CD4-CD8-TCR-alphabeta+ T-cell lymphoma with clinical features of primary effusion lymphoma: an autopsy case.

Authors:  Y Yamamoto; H Kitajima; H Sakihana; T Shigeki; S Fukuhara
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

2.  MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).

Authors:  M Osaka; J D Rowley; N J Zeleznik-Le
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

3.  Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.

Authors:  Laurie E Risner; Aravinda Kuntimaddi; Alyson A Lokken; Nicholas J Achille; Noah W Birch; Kelly Schoenfelt; John H Bushweller; Nancy J Zeleznik-Le
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

4.  Nuclear punctate distribution of ALL-1 is conferred by distinct elements at the N terminus of the protein.

Authors:  T Yano; T Nakamura; J Blechman; C Sorio; C V Dang; B Geiger; E Canaani
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation.

Authors:  C Caslini; A Shilatifard; L Yang; J L Hess
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

6.  No chromosome arm unturned: in memory of Roland Berger 1934-2012.

Authors:  C J Harrison; J D Rowley; H Van den Berghe; A Bernheim; M Martineau; M Gautier; M Le Coniat-Busson; S Romana; N Dastugue; A Hagemeijer; P Jonveaux; F Nguyen-Khac; O A Bernard
Journal:  Leukemia       Date:  2014-02       Impact factor: 11.528

7.  The partial tandem duplication of ALL1 in acute myeloid leukemia with normal cytogenetics or trisomy 11 is restricted to one chromosome.

Authors:  M A Caligiuri; M P Strout; A R Oberkircher; F Yu; A de la Chapelle; C D Bloomfield
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

8.  The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia.

Authors:  M P Strout; G Marcucci; C D Bloomfield; M A Caligiuri
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

9.  The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q.

Authors:  A Borkhardt; S Bojesen; O A Haas; U Fuchs; D Bartelheimer; I F Loncarevic; R M Bohle; J Harbott; R Repp; U Jaeger; S Viehmann; T Henn; P Korth; D Scharr; F Lampert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

10.  The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.

Authors:  R T Luo; C Lavau; C Du; F Simone; P E Polak; S Kawamata; M J Thirman
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.